| Who owns this joint? As a result of the vacuum created by the withdrawal of COX-2 inhibitor drugs, fierce competition rages on between the medical and ... An article from: Nutraceuticals World | Digitalby David Mark (Author)
| List Price: | $5.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Thomson Gale | | Page Count: | 16 Pages | | Publication Date: | October 01, 2005 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Nutraceuticals World, published by Thomson Gale on October 1, 2005. The length of the article is 4612 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Who owns this joint? As a result of the vacuum created by the withdrawal of COX-2 inhibitor drugs, fierce competition rages on between the medical and supplement industries, which are both vying for consumers that suffer from various joint ailments.(BONE & JOINT HEALTH)Author: David MarkPublication: Nutraceuticals World (Magazine/Journal)Date: October 1, 2005Publisher: Thomson GaleVolume: 8 Issue: 9 Page: 60(7)Distributed by Thomson Gale |
|
